SUNScholar
metadata only
CC BY 4.0
Pharmacokinetics and safety of group A and B Anti-Tuberculosis drugs used in treatment of Rifampicin-Resistant tuberculosis during pregnancy and Post-Partum: A narrative review
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of pyrazinamide and/or ethambutol resistance on Tuberculosis treatment outcome by whole genome sequencing, South Africa 2020 – 2022#447668
- Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants#633751
- Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis#811598
- Transformer-accelerated discovery of inhibitors targeting the RpsA(Δ438) deletion in PZA-resistant tuberculosis.#645610
- A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis#28367
Record · ID 197711
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive